[HTML][HTML] Combination of UGT1A1 polymorphism and baseline plasma bilirubin levels in predicting the risk of antipsychotic-induced dyslipidemia in schizophrenia …
C Lin, S Zhang, P Yang, B Zhang, W Guo, R Wu, Y Liu… - Schizophrenia, 2024 - nature.com
The prolonged usage of atypical antipsychotic drugs (AAPD) among individuals with
schizophrenia often leads to metabolic side effects such as dyslipidemia. These effects not …
schizophrenia often leads to metabolic side effects such as dyslipidemia. These effects not …
[HTML][HTML] Asian-European differentiation of schizophrenia-associated genes driven by admixture and natural selection
S Chen, D Tang, L Deng, S Xu - Iscience, 2024 - cell.com
The European-centered genome-wide association studies of schizophrenia (SCZ) may not
be well applied to non-European populations. We analyzed 1,592 reported SCZ-associated …
be well applied to non-European populations. We analyzed 1,592 reported SCZ-associated …